Toshihisa Anzai
University of California, San Diego
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Toshihisa Anzai.
Circulation | 1999
Mei Hua Gao; N. Chin Lai; David Roth; Jinyao Zhou; Jian Zhu; Toshihisa Anzai; Nancy D. Dalton; H. Kirk Hammond
BACKGROUNDnThe cellular content of cAMP generated by activation of adenylylcyclase (AC) through the beta-adrenergic receptor (betaAR) is a key determinant of a cells response to catecholamine stimulation. We tested the hypothesis that increased AC content, independently of betaAR number, increases responsiveness to catecholamine stimulation in vivo.nnnMETHODS AND RESULTSnTransgenic mice with cardiac-directed expression of ACVI showed increased transgene AC expression but no change in myocardial betaAR number or G-protein content. When stimulated through the betaAR, cardiac function was increased, and cardiac myocytes showed increased cAMP production. In contrast, basal cAMP and cardiac function were normal, and long-term transgene expression was not associated with abnormal histological findings or deleterious changes in cardiac function.nnnCONCLUSIONSnThe amount of AC sets a limit on cardiac beta-adrenergic signaling in vivo, and increased AC, independent of betaAR number and G-protein content, provides a means to regulate cardiac responsiveness to betaAR stimulation. Overexpressing an effector (AC) does not alter transmembrane signaling except when receptors are activated, in contrast to receptor/G-protein overexpression, which yields continuous activation and has detrimental consequences. Our findings establish the importance of AC content in modulating beta-adrenergic signaling in the heart, suggesting a new target for safely increasing cardiac responsiveness to betaAR stimulation.
Journal of the American College of Cardiology | 1996
Toshihisa Anzai; Tsutomu Yoshikawa; Akiyasu Baba; Hiroshi Nishimura; Hiroto Shiraki; Keiichi Nagami; Masahiro Suzuki; Yumiko Wainai; Satoshi Ogawa
OBJECTIVESnThe purpose of this study was to assess the effect of myocardial sympathetic denervation on the chamber-specific alteration of beta-adrenergic signaling in left ventricular failure in rabbits.nnnBACKGROUNDnLocal abnormalities in sympathetic nerve terminals, including the neuronal reuptake of norepinephrine, are thought to be responsible for the chamber-specific regulation of beta-adrenergic signaling in heart failure.nnnMETHODSnSixteen rabbits were given 6-hydroxydopamine, 25 mg/kg body weight intravenously on days 1 and 2 and 50 mg/kg intravenously on days 7 and 8. Another 16 rabbits received vehicle. Aortic regurgitation was induced in eight of the 6-hydroxydopamine-treated and eight of the vehicle-treated rabbits on day 14. Another eight of the 6-hydroxydopamine-treated and eight of the vehicle-treated rabbits underwent a sham operation. The hearts were excised for biochemical analysis on day 21.nnnRESULTSnHemodynamic characteristics on day 21 showed left ventricular failure in both the aortic regurgitation groups. The plasma norepinephrine concentration on day 21 was higher in both the aortic regurgitation groups than in the sham groups. The beta-adrenoceptor densities and isoproterenol plus 5-guanylylimidodiphosphate-, 5-guanylylimidodiphosphate- and sodium fluoride-stimulated adenylyl cyclase activities were decreased only in the failing left ventricle of the vehicle-pretreated aortic regurgitation group, but in both ventricles of the 6-hydroxydopamine-pretreated aortic regurgitation group. The basal and forskolin-stimulated adenylyl cyclase activities were similar in both the aortic regurgitation groups and in the sham groups.nnnCONCLUSIONSnSympathetic denervation prevented chamber-specific alterations in beta-adrenergic signaling in acute left ventricular failure. Local loss of sympathetic nerve endings, and especially the defective neuronal norepinephrine reuptake, are likely to be responsible for the chamber-specific alteration of the beta-adrenoceptor-G protein-adenylyl cyclase system in heart failure in rabbits.
/data/revues/00029149/unassign/S0002914917319306/ | 2018
Yasuhiro Hamatani; Toshiyuki Nagai; Yasuyuki Shiraishi; Shun Kohsaka; Michikazu Nakai; Kunihiro Nishimura; Takashi Kohno; Yuji Nagatomo; Yasuhide Asaumi; Ayumi Goda; Atsushi Mizuno; Satoshi Yasuda; Hisao Ogawa; Tsutomu Yoshikawa; Toshihisa Anzai
Archive | 2016
Atsushi Okada; Yasuo Sugano; Toshiyuki Nagai; Seiji Takashio; Satoshi Honda; Yasuhide Asaumi; Takeshi Aiba; Teruo Noguchi; Kengo Kusano; Hisao Ogawa; Satoshi Yasuda; Toshihisa Anzai
The Japanese Journal of Sarcoidosis and Other Granulomatous Disorders | 2012
Toshiyuki Nagai; Shun Kohsaka; Shigeo Okuda; Koichiro Asano; Toshihisa Anzai; Keiichi Fukuda
Archive | 2011
Toshiyuki Nagai; Toshihisa Anzai; Hidehiro Kaneko; Yoshinori Mano; Atsushi Anzai; Yuichiro Maekawa; Tsutomu Yoshikawa; Keiichi Fukuda
/data/revues/00028703/v131i2/S0002870396903622/ | 2011
Tsutomu Yoshikawa; Shunnosuke Handa; Toshihisa Anzai; Hiroshi Nishimura; Akiyasu Baba; Makoto Akaishi; Hideo Mitamura; Satoshi Ogawa
Archive | 2010
Toshiyuki Takahashi; Shiro Ishikawa; Hideo Mitamura; Satoshi Ogawa; Yuichiro Maekawa; Toshihisa Anzai; Tsutomu Yoshikawa; Yasushi Asakura
Archive | 2010
Takashi Kohno; Toshiyuki Takahashi; Satoshi Ogawa; Yuichiro Maekawa; Toshihisa Anzai; Tsutomu Yoshikawa; Yasuo Sugano
Archive | 2010
Keitaro Mahara; Michikado Iwata; H. Kirk Hammond; Satoshi Ogawa; Toshiyuki Takahashi; Toshihisa Anzai; Tsutomu Yoshikawa; Yuichiro Maekawa